Signal #150041 · SEC 8-K

$JANX SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $JANX filing catalyst

Why did $JANX trigger an AI stock catalyst alert?

$JANX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Janux Therapeutics Reports Q3 Net Loss of $21.6M, JANX011 Phase 1 Data Set for Nov 9. Key points: - Q3 net loss decreased to $21.6M ($0.34 per share) from $24.3M ($0.39 per share) year-over-year. - R&D expenses declined to $30.6M vs. $34.6M in Q3 2025. - Phase 1 healthy-volunteer data for JANX011 scheduled for webcast presentation on Nov 9, 2026.

How did $JANX stock react after the SEC filing?

After the SEC 8-K for $JANX, observed market reaction: T0 price $16.06. Past moves do not guarantee future results.

Where can I get real-time $JANX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $JANX via Telegram and the VIP Web Terminal from €10/month.

$JANX

$JANX – Janux Therapeutics Reports Q3 Net Loss of $21.6M, JANX011 Phase 1 Data Set for Nov 9

Janux Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $JANX

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (+0.5 / 10)

Q3 net loss decreased to $21.6M ($0.34 per share) from $24.3M ($0.39 per share) year-over-year.
R&D expenses declined to $30.6M vs. $34.6M in Q3 2025.
Phase 1 healthy-volunteer data for JANX011 scheduled for webcast presentation on Nov 9, 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →